Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Genprex Inc (NQ: GNPX)
2.840 USD  +0.070 (+2.53%)
Official Closing Price  /  Updated: 7:57 PM EDT, May 29, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,000,310
Open 2.770
Bid (Size) 2.800 (4)
Ask (Size) 2.850 (5)
Prev. Close 2.770
Today's Range 2.660 - 2.850
52wk Range 0.2310 - 7.030
Shares Outstanding 13,896,926
Dividend Yield N/A
Performance
YTD
+816.13%
+816.13%
1 Month
+21.37%
+21.37%
3 Month
-30.82%
-30.82%
6 Month
+951.85%
+951.85%
1 Year
+77.50%
+77.50%
Top News
More News
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises Read More
from Business Wire News Releases
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Secures $2.5 Million in Cash Proceeds from Recent Warrant Exercises
from InvestorBrandNetwork
More News
Read More
Biotech Brief: Global Market For Cancer Drug Candidates Could Exceed US$220 Billion By 2025
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotech Brief: Global Market for Cancer Drug Candidates Could Exceed US$220 Billion by 2025
from PR Newswire
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Oncology Franchise via Exclusive Worldwide Patent and Technology License Agreement
from InvestorBrandNetwork
Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies
from Business Wire News Releases
3 Penny Stocks To Watch With “Strong Buy” Ratings
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Genprex Issues April 2020 Shareholder Letter
from Business Wire News Releases
Mid-Afternoon Market Update: NASDAQ Surges More Than 2%; Itron Shares Slide
category PTLA , Benzinga , Intraday Update , and 16 more.
from Benzinga
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Shareholder Letter Highlighting Oncoprex(TM) Progress, License Agreement for a Diabetes Drug Candidate and Other Achievements
from InvestorBrandNetwork
Why Are Shares Of Gene Therapy Company Genprex AreSurging Higher
category Contracts , Trading Ideas , Movers , and 7 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]